We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

J&J Staves Off Generic Topamax

Law360 (February 13, 2007, 12:00 AM EST) -- A federal judge has sided with a Johnson & Johnson company in a patent infringement case over Topamax, keeping Mylan Laboratories Inc.’s generic version of the epilepsy drug off the shelf.

Earlier this month, Judge Stanley R. Chesler of the U.S. District Court for the District of New Jersey rejected Mylan’s arguments that Ortho-McNeil Pharmaceutical Inc.’s patent was invalid due to obviousness, and granted Ortho-McNeil’s motion for partial summary judgment.

Mylan had contended that Ortho-McNeil’s patent on Topamax covered subject matter considered obvious to an individual...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.